These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1969772)

  • 21. The pharmacology of fenoldopam.
    Nichols AJ; Ruffolo RR; Brooks DP
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs.
    Halpenny M; Markos F; Snow HM; Duggan PF; Gaffney E; O'Connell DP; Shorten GD
    Crit Care Med; 2001 Apr; 29(4):855-60. PubMed ID: 11373482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.
    Brooks DP; DePalma PD; Cyronak MJ; Bryant MA; Karpinski K; Mico B; Gaitanopoulos DE; Chambers PA; Erhard KF; Weinstock J
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1084-9. PubMed ID: 1975620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients.
    Jorkasky DK; Audet P; Shusterman N; Ilson B; Dafoe D; Hedrich D; Stote RM
    Am J Kidney Dis; 1992 Jun; 19(6):567-72. PubMed ID: 1350709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine and dopamine receptor agonists in cardiovascular therapy.
    Murphy MB; Elliott WJ
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S14-8. PubMed ID: 1967161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal and endocrine effects of fenoldopam and metoclopramide in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Nephron; 1990; 56(2):179-85. PubMed ID: 1978736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
    Brooks DP; DePalma PD; Cyronak MJ; Karpinski K; Weinstock J
    Pharmacology; 1990; 41(5):299-308. PubMed ID: 1982634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
    Horn PT; Kohli JD
    Eur J Pharmacol; 1991 May; 197(2-3):125-30. PubMed ID: 1680707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of fenoldopam on renal blood flow and tubular function during aortic cross-clamping in anaesthetized dogs.
    Halpenny M; Markos F; Snow HM; Duggan PF; Gaffney E; O'Connell DP; Shorten GD
    Eur J Anaesthesiol; 2000 Aug; 17(8):491-8. PubMed ID: 10998032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human vasodilator responses to a dopamine agonist: possible mechanisms.
    Redman D; Thom SA; Hughes AD; Hasan S; Sever PS
    J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans.
    Horton R; Bughi S; Jost-Vu E; Antonipillai I; Nadler J
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):108S-111S. PubMed ID: 1974438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam.
    Brooks DP; Drutz DJ; Ruffolo RR
    J Pharmacol Exp Ther; 1990 Aug; 254(2):375-9. PubMed ID: 1974632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM
    Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Br J Clin Pharmacol; 1990 Apr; 29(4):413-5. PubMed ID: 1970264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
    Gretler DD; Elliott WJ; Moscucci M; Childers RW; Murphy MB
    Arch Intern Med; 1992 Dec; 152(12):2445-8. PubMed ID: 1360793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans.
    Ragsdale NV; Lynd M; Chevalier RL; Felder RA; Peach MJ; Carey RM
    Hypertension; 1990 Jun; 15(6 Pt 2):914-21. PubMed ID: 1972140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative DA1-dopamine-receptor agonist and alpha-adrenoceptor antagonist activity of fenoldopam in the anesthetized dog.
    Kohli JD; Glock D; Goldberg LI
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):123-6. PubMed ID: 2450250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery.
    Hill AJ; Feneck RO; Walesby RK
    J Cardiothorac Vasc Anesth; 1993 Jun; 7(3):279-84. PubMed ID: 8100152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous fenoldopam infusion in severe heart failure.
    Patel JJ; Mitha AS; Sareli P; de Vaal JB
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):97-101. PubMed ID: 8097927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
    Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.